Industry: Global BioTech
Request: An international pharmaceutical company intending to undertake clinical trials in Australia, requested Clearpoint Ventures to assist and guide their staff on matters pertaining to R&D Tax Incentive claims.
How we helped:
Our team hit the ground running, providing R&D Tax advice and round-the-clock support to their overseas and Australian staff at a fixed cost. With our background in science and biotechnology, and strong contacts within those industries, we were able to help our client successfully negotiate agreements with large, trusted Australian clinical trial organisations.
This is part of our new initiative to both boost local expertise and the economy, whilst fostering more overseas and local collaborations. With our proven and practical approach to ensuring maximum R&D Tax returns, we are guiding our client through the Australian R&D Tax process, including the establishment of an Australian entity, appointing a resident Director, tracking their R&D activities and costs, including monitoring their collaborative contracts and documentation with the CROs (clinical research organisations).